Bacil Pharma Ltd

NSE: BACPHAR · BSE: 524516 · Pharmaceuticals & Biotechnology · 25 announcements

Share price: ₹25.50
Market cap: ₹36.60 Cr
Revenue (annual): ₹0.00 Cr
Net profit (annual): ₹1.56 Cr
P/E (TTM): 55.8×Sector 47.4×
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 5 Board Meeting Date 5 Fund Raise 3 Financial Results 3 Merger & Restructuring 2 Board Meeting Outcome 2 Management Change 1 Capital Structure Change 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

28 Jul 2026 18:31 IST BSE

Merger & Restructuring

Bacil Pharma Merger & Restructuring

Bacil Pharma Limited has incorporated a wholly-owned subsidiary named BACIL RESEARCH & DEVELOPMENT PRIVATE LIMITED. This strategic move expands the company's corporate structure.

Read the filing ↗

7 Jul 2026 19:16 IST BSE

Merger & Restructuring

Bacil Pharma Merger & Restructuring

Bacil Pharma Ltd received approval for the name of its proposed wholly-owned subsidiary. Incorporation is underway, pending final Certificate of Incorporation.

Read the filing ↗